Mechanistic Modeling of Spatial Heterogeneity of Drug Penetration and Exposure in the Human Central Nervous System and Brain Tumors

Documenti analoghi

• SpatialCNS‐PBPK: An R/Shiny Web‐Based Application for Physiologically Based Pharmacokinetic Modeling of Spatial Pharmacokinetics in the Human Central Nervous System and Brain Tumors
  di: Charuka D. Wickramasinghe, et al.
  Pubblicazione: (2025)
• Methotrexate‐Induced Nephrotoxicity and Exposure Thresholds in Primary Central Nervous System Lymphoma: A Population PKPD Model
  di: Ruoyun Wu, et al.
  Pubblicazione: (2026)
• Gut Microbiota in Patients with Tuberculosis Associated with Different Drug Exposures of Antituberculosis Drugs
  di: Yue Zhu, et al.
  Pubblicazione: (2025)
• Longitudinal Tumor Size and Survival Modeling for Exposure–Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer
  di: Emmanuel Chigutsa, et al.
  Pubblicazione: (2026)
• Prediction of Local Drug Exposure of Dry Powder Inhaler CXG87 (budesonide/formoterol) Using Physiologically‐Based Pharmacokinetic Model
  di: Yuran Cao, et al.
  Pubblicazione: (2025)